Oesophageal Atresia: Prevalence in the Valencian Region (Spain) and Associated Anomalies

Author:

Agurto-Ramírez Adriana1ORCID,García-Villodre Laura2ORCID,Ruiz-Palacio Ana2,Arribas-Díaz Berta2ORCID,Barrachina-Bonet Laia2ORCID,Páramo-Rodríguez Lucía2ORCID,Zurriaga Óscar234ORCID,Cavero-Carbonell Clara2ORCID

Affiliation:

1. Service of Preventive Medicine, Valencia General University Hospital Consortium, 46014 Valencia, Spain

2. Rare Diseases Joint Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region-Valencia University (FISABIO-UVEG), 46020 Valencia, Spain

3. Public Health Regional Health Administration, Generalitat Valenciana, 46020 Valencia, Spain

4. Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Legal Medicine, University of Valencia, 46010 Valencia, Spain

Abstract

The objective was to determine the prevalence of oesophageal atresia (OA) and describe the characteristics of OA cases diagnosed before the first year of life, born between 2007 and 2019, and residents in the Valencian Region (VR), Spain. Live births (LB), stillbirths (SB), and termination of pregnancy for fetal anomaly (TOPFA) diagnosed with OA were selected from the Congenital Anomalies population-based Registry of VR (RPAC-CV). The prevalence of OA per 10,000 births with 95% confidence interval was calculated, and socio-demographic and clinical variables were analyzed. A total of 146 OA cases were identified. The overall prevalence was 2.4/10,000 births, and prevalence by type of pregnancy ending was 2.3 in LB and 0.03 in both SB and TOPFA. A mortality rate of 0.03/1000 LB was observed. A relationship was found between case mortality and birth weight (p-value < 0.05). OA was primarily diagnosed at birth (58.2%) and 71.2% of the cases were associated with another congenital anomaly, mainly congenital heart defects. Significant variations in the prevalence of OA in the VR were detected throughout the study period. In conclusion, a lower prevalence in SB and TOPFA was identified compared to EUROCAT data. As several studies have identified, an association between OA cases and birth weight was found.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference26 articles.

1. Pr Lewis, S. (2022, October 10). Atresia of the Esophagus ORPHA:1199. Available online: https://www.orpha.net/consor4.01/www/cgi-bin/Disease_Search.php?lng=ES&data_id=724&MISSING%20CONTENT=Atresia-de-es-fago&search=Disease_Search_Simple&title=Atresia%20de%20es%F3fago.

2. Current knowledge on esophageal atresia;Pinheiro;World J. Gastroenterol.,2012

3. Health Organization (WHO) (2022, October 10). Premature Births n.d. Available online: https://www.who.int/es/news-room/fact-sheets/detail/preterm-birth.

4. European Commission (2022, October 10). Health & Consumer Protection Directorate General. Useful Information on Rare Diseases from an EU Perspective. Available online: https://ec.europa.eu/health/ph_information/documents/ev20040705_rd05_en.pdf.

5. EUROCAT (2022, October 10). Prevalence Charts and Tables 2021. Available online: https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3